 | • レポートコード：MRC2012A2703 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、皮膚科用医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。皮膚科用医薬品の種類別市場規模（外用、経口、注射）、用途別市場規模（乾癬、皮膚感染症、ニキビ、皮膚炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Merz Pharma、Galderma、Johnson & Johnson、Pfizer、Bayer、LEO Pharma、Novartis、Bristol-Myers Squibb、Bausch Health Companies Inc、GlaxoSmithKline、 ・地域別グローバル市場分析 2015年-2020年 ・皮膚科用医薬品の北米市場（アメリカ、カナダ、メキシコ） ・皮膚科用医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・皮膚科用医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・皮膚科用医薬品の南米市場（ブラジル、アルゼンチン） ・皮膚科用医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：外用、経口、注射 ・用途別分析：乾癬、皮膚感染症、ニキビ、皮膚炎、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Dermatology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 31520 million by 2025, from USD 25450 million in 2019.
The Dermatology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Dermatology Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Dermatology Drugs market has been segmented into
External Use
Oral
Injection
By Application, Dermatology Drugs has been segmented into:
Psoriasis
Skin Infections
Acne
Dermatitis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dermatology Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Dermatology Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dermatology Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Dermatology Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Dermatology Drugs Market Share Analysis
Dermatology Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dermatology Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dermatology Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Dermatology Drugs are:
AbbVie
Merz Pharma
Galderma
Johnson & Johnson
Pfizer
Bayer
LEO Pharma
Novartis
Bristol-Myers Squibb
Bausch Health Companies Inc
GlaxoSmithKline
Among other players domestic and global, Dermatology Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dermatology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dermatology Drugs, with price, sales, revenue and global market share of Dermatology Drugs in 2018 and 2019.
Chapter 3, the Dermatology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dermatology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dermatology Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dermatology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Dermatology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dermatology Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 External Use
1.2.3 Oral
1.2.4 Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Dermatology Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Psoriasis
1.3.3 Skin Infections
1.3.4 Acne
1.3.5 Dermatitis
1.3.6 Other
1.4 Overview of Global Dermatology Drugs Market
1.4.1 Global Dermatology Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merz Pharma
2.2.1 Merz Pharma Details
2.2.2 Merz Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merz Pharma SWOT Analysis
2.2.4 Merz Pharma Product and Services
2.2.5 Merz Pharma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Galderma
2.3.1 Galderma Details
2.3.2 Galderma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Galderma SWOT Analysis
2.3.4 Galderma Product and Services
2.3.5 Galderma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Pfizer SWOT Analysis
2.5.4 Pfizer Product and Services
2.5.5 Pfizer Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 LEO Pharma
2.7.1 LEO Pharma Details
2.7.2 LEO Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 LEO Pharma SWOT Analysis
2.7.4 LEO Pharma Product and Services
2.7.5 LEO Pharma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis SWOT Analysis
2.8.4 Novartis Product and Services
2.8.5 Novartis Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb SWOT Analysis
2.9.4 Bristol-Myers Squibb Product and Services
2.9.5 Bristol-Myers Squibb Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bausch Health Companies Inc
2.10.1 Bausch Health Companies Inc Details
2.10.2 Bausch Health Companies Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bausch Health Companies Inc SWOT Analysis
2.10.4 Bausch Health Companies Inc Product and Services
2.10.5 Bausch Health Companies Inc Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 GlaxoSmithKline
2.11.1 GlaxoSmithKline Details
2.11.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 GlaxoSmithKline SWOT Analysis
2.11.4 GlaxoSmithKline Product and Services
2.11.5 GlaxoSmithKline Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dermatology Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dermatology Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dermatology Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Dermatology Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dermatology Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Dermatology Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dermatology Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Dermatology Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Dermatology Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dermatology Drugs Sales and Growth Rate (2015-2020)
4.5 South America Dermatology Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dermatology Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dermatology Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Dermatology Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Dermatology Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Dermatology Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Dermatology Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Dermatology Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dermatology Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Dermatology Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dermatology Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Dermatology Drugs Sales and Growth Rate (2015-2020)
6.3 UK Dermatology Drugs Sales and Growth Rate (2015-2020)
6.4 France Dermatology Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Dermatology Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Dermatology Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dermatology Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dermatology Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dermatology Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Dermatology Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Dermatology Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Dermatology Drugs Sales and Growth Rate (2015-2020)
7.5 India Dermatology Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dermatology Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Dermatology Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dermatology Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Dermatology Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Dermatology Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dermatology Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Dermatology Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dermatology Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dermatology Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dermatology Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dermatology Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Dermatology Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Dermatology Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Dermatology Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dermatology Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Dermatology Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Dermatology Drugs Price by Type (2015-2020)
11 Global Dermatology Drugs Market Segment by Application
11.1 Global Dermatology Drugs Sales Market Share by Application (2015-2020)
11.2 Global Dermatology Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Dermatology Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dermatology Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Dermatology Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Dermatology Drugs Market Forecast (2021-2025)
12.2.2 Europe Dermatology Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dermatology Drugs Market Forecast (2021-2025)
12.2.4 South America Dermatology Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dermatology Drugs Market Forecast (2021-2025)
12.3 Dermatology Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Dermatology Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Dermatology Drugs Market Share Forecast by Type (2021-2025)
12.4 Dermatology Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Dermatology Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Dermatology Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Dermatology Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dermatology Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dermatology Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Dermatology Drugs Major Business
Table 9. AbbVie Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Dermatology Drugs Product and Services
Table 12. AbbVie Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Merz Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Merz Pharma Dermatology Drugs Major Business
Table 15. Merz Pharma Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Merz Pharma SWOT Analysis
Table 17. Merz Pharma Dermatology Drugs Product and Services
Table 18. Merz Pharma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Galderma Basic Information, Manufacturing Base and Competitors
Table 20. Galderma Dermatology Drugs Major Business
Table 21. Galderma Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Galderma SWOT Analysis
Table 23. Galderma Dermatology Drugs Product and Services
Table 24. Galderma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 26. Johnson & Johnson Dermatology Drugs Major Business
Table 27. Johnson & Johnson Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Johnson & Johnson SWOT Analysis
Table 29. Johnson & Johnson Dermatology Drugs Product and Services
Table 30. Johnson & Johnson Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Pfizer Basic Information, Manufacturing Base and Competitors
Table 32. Pfizer Dermatology Drugs Major Business
Table 33. Pfizer Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Pfizer SWOT Analysis
Table 35. Pfizer Dermatology Drugs Product and Services
Table 36. Pfizer Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Bayer Basic Information, Manufacturing Base and Competitors
Table 38. Bayer Dermatology Drugs Major Business
Table 39. Bayer Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Bayer SWOT Analysis
Table 41. Bayer Dermatology Drugs Product and Services
Table 42. Bayer Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. LEO Pharma Basic Information, Manufacturing Base and Competitors
Table 44. LEO Pharma Dermatology Drugs Major Business
Table 45. LEO Pharma Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 46. LEO Pharma SWOT Analysis
Table 47. LEO Pharma Dermatology Drugs Product and Services
Table 48. LEO Pharma Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Novartis Basic Information, Manufacturing Base and Competitors
Table 50. Novartis Dermatology Drugs Major Business
Table 51. Novartis Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Novartis SWOT Analysis
Table 53. Novartis Dermatology Drugs Product and Services
Table 54. Novartis Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 56. Bristol-Myers Squibb Dermatology Drugs Major Business
Table 57. Bristol-Myers Squibb Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Bristol-Myers Squibb SWOT Analysis
Table 59. Bristol-Myers Squibb Dermatology Drugs Product and Services
Table 60. Bristol-Myers Squibb Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bausch Health Companies Inc Basic Information, Manufacturing Base and Competitors
Table 62. Bausch Health Companies Inc Dermatology Drugs Major Business
Table 63. Bausch Health Companies Inc Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Bausch Health Companies Inc SWOT Analysis
Table 65. Bausch Health Companies Inc Dermatology Drugs Product and Services
Table 66. Bausch Health Companies Inc Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 68. GlaxoSmithKline Dermatology Drugs Major Business
Table 69. GlaxoSmithKline Dermatology Drugs Total Revenue (USD Million) (2017-2018)
Table 70. GlaxoSmithKline SWOT Analysis
Table 71. GlaxoSmithKline Dermatology Drugs Product and Services
Table 72. GlaxoSmithKline Dermatology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Global Dermatology Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 74. Global Dermatology Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 75. Global Dermatology Drugs Sales by Regions (2015-2020) (K Units)
Table 76. Global Dermatology Drugs Sales Market Share by Regions (2015-2020)
Table 77. Global Dermatology Drugs Revenue by Regions (2015-2020) (USD Million)
Table 78. North America Dermatology Drugs Sales by Countries (2015-2020) (K Units)
Table 79. North America Dermatology Drugs Sales Market Share by Countries (2015-2020)
Table 80. North America Dermatology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 81. North America Dermatology Drugs Revenue Market Share by Countries (2015-2020)
Table 82. Europe Dermatology Drugs Sales by Countries (2015-2020) (K Units)
Table 83. Europe Dermatology Drugs Sales Market Share by Countries (2015-2020)
Table 84. Europe Dermatology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 85. Asia-Pacific Dermatology Drugs Sales by Regions (2015-2020) (K Units)
Table 86. Asia-Pacific Dermatology Drugs Sales Market Share by Regions (2015-2020)
Table 87. Asia-Pacific Dermatology Drugs Revenue by Regions (2015-2020) (USD Million)
Table 88. South America Dermatology Drugs Sales by Countries (2015-2020) (K Units)
Table 89. South America Dermatology Drugs Sales Market Share by Countries (2015-2020)
Table 90. South America Dermatology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. South America Dermatology Drugs Revenue Market Share by Countries (2015-2020)
Table 92. Middle East & Africa Dermatology Drugs Sales by Countries (2015-2020) (K Units)
Table 93. Middle East & Africa Dermatology Drugs Sales Market Share by Countries (2015-2020)
Table 94. Middle East & Africa Dermatology Drugs Revenue by Countries (2015-2020) (USD Million)
Table 95. Middle East & Africa Dermatology Drugs Revenue Market Share by Countries (2015-2020)
Table 96. Global Dermatology Drugs Sales by Type (2015-2020) (K Units)
Table 97. Global Dermatology Drugs Sales Share by Type (2015-2020)
Table 98. Global Dermatology Drugs Revenue by Type (2015-2020) (USD Million)
Table 99. Global Dermatology Drugs Revenue Share by Type (2015-2020)
Table 100. Global Dermatology Drugs Sales by Application (2015-2020) (K Units)
Table 101. Global Dermatology Drugs Sales Share by Application (2015-2020)
Table 102. Global Dermatology Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 103. Global Dermatology Drugs Market Share Forecast by Regions (2021-2025)
Table 104. Global Dermatology Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 105. Global Dermatology Drugs Market Share Forecast by Type (2021-2025)
Table 106. Global Dermatology Drugs Sales Forecast by Application (2021-2025)
Table 107. Global Dermatology Drugs Market Share Forecast by Application (2021-2025)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dermatology Drugs Picture
Figure 2. Global Sales Market Share of Dermatology Drugs by Type in 2019
Figure 3. External Use Picture
Figure 4. Oral Picture
Figure 5. Injection Picture
Figure 6. Dermatology Drugs Sales Market Share by Application in 2018
Figure 7. Psoriasis Picture
Figure 8. Skin Infections Picture
Figure 9. Acne Picture
Figure 10. Dermatitis Picture
Figure 11. Other Picture
Figure 12. Global Dermatology Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Dermatology Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Dermatology Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Dermatology Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Dermatology Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Dermatology Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Dermatology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Dermatology Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Dermatology Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Dermatology Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Dermatology Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Dermatology Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Dermatology Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Dermatology Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Dermatology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Dermatology Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Dermatology Drugs Sales Market Share by Countries in 2018
Figure 49. North America Dermatology Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Dermatology Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Dermatology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Dermatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Dermatology Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Dermatology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Dermatology Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Dermatology Drugs Revenue Market Share by Regions 2019
Figure 65. China Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Dermatology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Dermatology Drugs Sales Market Share by Countries in 2019
Figure 72. South America Dermatology Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Dermatology Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Dermatology Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Dermatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Dermatology Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Dermatology Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Dermatology Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Dermatology Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Dermatology Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Dermatology Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Dermatology Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Dermatology Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Dermatology Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
アトピー性皮膚炎薬の世界市場（～2026年） Atopic dermatitis (AD) is a pruritic disease of unknown origin that usually starts in early infancy (an adult-onset variant is recognized). One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated …- 皮膚科治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dermatology Therapeutics Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatology …
- 皮膚科診断用装置・治療の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dermatology Diagnostic Devices and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1115 million by 2025, from USD 960.5 million in 2…
- 爪囲炎治療薬の世界市場（～2026年） Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to…
- ニキビ薬品の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Acne Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Acne Drugs market report provides …